Research and Markets: The Slovak Pharmaceutical Market Is Estimated To Expand At A Moderate CAGR between 2010 And 2015

DUBLIN--(BUSINESS WIRE)-- Research and Markets ( has announced the addition of the "The Pharmaceutical Market: Slovakia" report to their offering.

These highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting the pharmaceutical market in context. The reports provide:

Five-year projections for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators.

Specialized intelligence on OTCs, generics, biologics and biosimilars.

Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the series.

A separate statistical health file, comprising health expenditure, health infrastructure, health services and health personnel.

The reports are updated quarterly, providing you with the latest information for a full year. In addition, the service will keep you up to date with market and industry news on a regular basis.

Executive Summary

Slovakia joined the EU in May 2004. The legal pharmaceutical framework is fully compliant with that of the EU and the intellectual property environment has improved. The United States Government removed Slovakia from the Special 301 Report Watch List in 2006.

The Slovak pharmaceutical market is estimated to expand at a moderate CAGR between 2010 and 2015. The majority of the pharmaceutical market is supplied by imports. Imports are sourced largely from EU-27 countries including Germany, France and the Czech Republic.

Funding for healthcare in Slovakia is principally through the health insurance system. The Slovak healthcare system is still very much in the public sector, although the majority of pharmacies and health spas are now privately-owned. Slovakia spends around 7.0% of GDP on healthcare.

Key Topics Covered:

  • Executive Summary
  • 2.Pharmaceutical Market
  • 3.Key National Data Projections
  • 4.Geography
  • 5.Political Overview
  • 6.Economic Overview
  • 7.Population
  • 8.Demographic Indicators
  • 9.Mortality
  • 10.Morbidity
  • 11.Organization & Administration
  • 12.Health Expenditure
  • 13.Hospital Services
  • 14.Ambulatory Care
  • 15.Medical Personnel
  • 16.Regulatory Environment
  • 17.Distribution Channels
  • 18.Pharmaceutical Imports
  • 19.Domestic Production & Exports
  • 20.Directory

Companies Mentioned:

  • Biotika
  • Imuna Pharm
  • Hoechst Biotika
  • Zentiva
  • SAFS
  • Phoenix
  • ADL

For more information visit

Source: Espicom Business Intelligence Ltd


Research and Markets
Laura Wood, Senior Manager,
[email protected]
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

KEYWORDS:   United States  Europe  North America  Slovakia  New York

INDUSTRY KEYWORDS:   Health  Pharmaceutical